ReviewInflammatory intestinal diseases2017
How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective.
Review in Inflammatory intestinal diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Ear, Nose, and Throat Manifestations in Inflammatory Bowel Diseases: A Systematic Review of the Clinical Spectrum.Medicina (Kaunas, Lithuania) · 2026Pooled it
- The importance of vitamin D levels in patients with inflammatory bowel disease.Journal of physiology and biochemistry · 2025Article
- Differential Manifestations of Inflammatory Bowel Disease Based on Race and Immigration Status.Gastro hep advances · 2024Article
- Article
- Changes in clinical features and seasonal variations of Crohn's disease at diagnosis: a 10-year observational study in China.Frontiers in medicine · 2024Article
- Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023Article
- Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn's disease: a KASID prospective multicenter study.Intestinal research · 2023Article
- Insight into gut dysbiosis of patients with inflammatory bowel disease and ischemic colitis.Frontiers in microbiology · 2023Article
- Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study.Gut and liver · 2022Article
- Characteristics of adult patients newly diagnosed with Crohn's disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn's disease in Japan (iCREST-CD).Journal of gastroenterology · 2022Observational
- Natural history of inflammatory bowel disease: a comparison between the East and the West.Intestinal research · 2022Review
- What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?Gut and liver · 2022Review
- Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?Intestinal research · 2022Review
- Changes in the Long-term Prognosis of Crohn's Disease between 1986 and 2015: The Population-Based Songpa-Kangdong Inflammatory Bowel Disease Cohort Study.Gut and liver · 2022Article
- Carbon 60 Dissolved in Grapeseed Oil Inhibits Dextran Sodium Sulfate-Induced Experimental Colitis.Journal of inflammation research · 2022Article
- Incident Crohn's Disease as a Risk Factor for Colorectal Cancer in the First 10 Years after Diagnosis: A Nationwide Population-Based Study.Journal of clinical medicine · 2021Article
- [Treatment of Inflammatory Bowel Disease in Elderly Patients - What Are Different and What Should We Know?]The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2021Review
- Disease burden of inflammatory bowel disease in China from 1990 to 2017: Findings from the global burden of diseases 2017.EClinicalMedicine · 2020Article
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.The lancet. Gastroenterology & hepatology · 2020Article
- Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease.World journal of gastrointestinal pathophysiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThough low compared with those in Western countries, the incidence and prevalence of inflammatory bowel disease (IBD) are rapidly increasing in Asia. If we could understand the differences in IBD epidemiology between Asian and Western countries, we might gain insights into the etiopathogenesis of IBD as well as guidance for personalized therapy. SUMMARY: In Asia, unlike in the West, Crohn's disease (CD) predominantly occurs in men and involves a high prevalence of perianal fistulas. Moreover, in Korean CD patients, ileocolonic involvement is predominant, whereas isolated colonic involvement is very uncommon. In both ulcerative colitis (UC) and CD, extraintestinal manifestations, such as primary sclerosing cholangitis, as well as a positive family history of IBD are less frequent in Asian patients. However, as the prevalence of IBD rises in Korea, so does the frequency of a positive family history. While the colectomy rate among Korean UC patients is lower, the intestinal resection rate in CD patients is similar in Korea and in the West. Infectious problems that can adversely influence IBD management are usually more common in Asia. KEY MESSAGES: IBD in Asians differs from that in Westerners in many aspects, including demographic and clinical characteristics, prognosis, and associated problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.